In 2024, Finland leads the use of non-steroids anti-inflammatory and antirheumatic medicine in Europe, with 78.7 units per thousand persons per day. Croatia and the Czech Republic follow, with notable consumption. Recent trends indicate increases in Iceland, Norway, and Slovenia, with Iceland showing the highest growth in 2023 (2.93%). Conversely, France, Hungary, Slovakia, and the Netherlands experienced declines, with the Netherlands witnessing the steepest decrease at 4.08%. A five-year analysis reveals varied trends, with certain countries showing consistent growth while others decline.
Future trends to watch include potential growth in eastern countries as healthcare access improves. In particular, nations with smaller rates may witness increased use due to aging populations and enhanced healthcare structures. Environmental and economic factors may also shift consumption patterns. Monitoring regulatory changes and new medical advancements will be crucial in forecasting the market dynamics in this sector.
Top countries in Non-Steroids Antiinflammatory and Antirheumatic Medicine Use by Country
| # | 10 Countries | Units (Defined Daily Dosage) Per Thousand Persons Per Day | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Finland | 78.7 | 2023 | 0% | -0.2% | View data |
| 2 | 2 Croatia | 58.4 | 2023 | +1.57% | -0.87% | View data |
| 3 | 3 Czech Republic | 56.4 | 2023 | -0.53% | -0.59% | View data |
| 4 | 4 Sweden | 55.2 | 2023 | -2.3% | +0.036% | View data |
| 5 | 5 Norway | 52.2 | 2023 | 0% | +1.99% | View data |
| 6 | 6 Slovenia | 49 | 2023 | +0.62% | +1.36% | View data |
| 7 | 7 Iceland | 44.6 | 2023 | +0.22% | +2.93% | View data |
| 8 | 8 Slovakia | 39.4 | 2023 | -1.01% | -1.6% | View data |
| 9 | 9 France | 30.3 | 2023 | +3.41% | -2.28% | View data |
| 10 | 10 Hungary | 24.6 | 2023 | -2.38% | -1.62% | View data |
